Differential effects of cathinone compounds andMDMAon body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia
Authors:
- 24 January 2013
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 168 (4) , 966-977
Abstract
Background and Purpose: Recreational users report that mephedrone has similar psychoactive effects to 3,4‐methylenedioxymethamphetamine (MDMA).MDMAinduces well‐characterized changes in body temperature due to complex monoaminergic effects on central thermoregulation, peripheral blood flow and thermogenesis, but there are little preclinical data on the acute effects of mephedrone or other synthetic cathinones.Experimental Approach: The acute effects of cathinone, methcathinone and mephedrone on rectal and tail temperature were examined in individually housed rats, withMDMAincluded for comparison. Rats were killed 2 h post‐injection and brain regions were collected for quantification of 5‐HT, dopamine and major metabolites. Further studies examined the impact of selected α‐adrenoceptor and dopamine receptor antagonists on mephedrone‐induced changes in rectal temperature and plasma catecholamines.Key Results: At normal room temperature,MDMAcaused sustained decreases in rectal and tail temperature. Mephedrone caused a transient decrease in rectal temperature, which was enhanced by α1‐adrenoceptor and dopamineD1receptor blockade, and a prolonged decrease in tail temperature. Cathinone and methcathinone caused sustained increases in rectal temperature.MDMAdecreased 5‐HTand/or 5‐hydroxyindoleacetic acid (5‐HIAA) content in several brain regions and reduced striatal homovanillic acid (HVA) levels, whereas cathinone and methcathinone increased striatalHVAand 5‐HIAA. Cathinone elevated striatal and hypothalamic 5‐HT. Mephedrone elevated plasma noradrenaline levels, an effect prevented by α‐adrenoceptor and dopamine receptor antagonists.Conclusions and Implications: MDMAand cathinones have different effects on thermoregulation, and their acute effects on brain monoamines also differ. These findings suggest that the adverse effects of cathinones in humans cannot be extrapolated from previous observations onMDMA.Keywords
This publication has 60 references indexed in Scilit:
- Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory StudyPLOS ONE, 2012
- The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain TissueNeuropsychopharmacology, 2011
- 4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of AbuseThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsBritish Journal of Pharmacology, 2011
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesBritish Journal of Pharmacology, 2010
- Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in ratsBritish Journal of Pharmacology, 2010
- Effects of Dose and Route of Administration on Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine in the RatDrug Metabolism and Disposition, 2009